A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris
Clinical trial NCT02106195 · COMPLETED
Trial details
- NCT number
- NCT02106195
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.